ACADIA Pharmaceuticals Inc.
ACAD
$15.35
-$0.77-4.78%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 213.87% | 150.27% | 2,897.22% | 138.48% | 209.76% |
| Total Depreciation and Amortization | 218.51% | 49.16% | 45.58% | 1,197.65% | 234.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -954.97% | 55.55% | -7.89% | 60.09% | 50.74% |
| Change in Net Operating Assets | 39.59% | 142.57% | -157.44% | -136.03% | 228.66% |
| Cash from Operations | -52.71% | 207.28% | 205.00% | 262.15% | 457.97% |
| Capital Expenditure | -- | -40.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6,791.07% | -341.18% | 71.08% | -107.29% | 98.04% |
| Cash from Investing | 35,301.73% | -341.74% | 71.08% | -107.29% | 98.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -63.77% | -97.90% | -34.92% | -28.85% | 236.68% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -63.77% | -97.90% | -34.92% | -28.85% | 236.68% |
| Foreign Exchange rate Adjustments | -400.00% | -950.00% | -- | 350.00% | -50.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 81.77% | -56.93% | 84.71% | -90.86% | 326.18% |
